Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
出版年份 2020 全文链接
标题
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
作者
关键词
-
出版物
Expert Opinion on Drug Metabolism & Toxicology
Volume 16, Issue 6, Pages 517-526
出版商
Informa UK Limited
发表日期
2020-04-10
DOI
10.1080/17425255.2020.1754793
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
- (2020) Jerome Sarris et al. BMC Psychiatry
- The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
- (2020) Salahaden R. Sultan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety
- (2020) Simona Lattanzi et al. CNS DRUGS
- Abrupt withdrawal of cannabidiol (CBD): A randomized trial
- (2020) Lesley Taylor et al. EPILEPSY & BEHAVIOR
- Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome
- (2020) Ian Miller et al. JAMA Neurology
- Is cannabidiol the ideal drug to treat non-motor Parkinson’s disease symptoms?
- (2019) José Alexandre S. Crippa et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review
- (2019) Eva Hoch et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Drug-drug interactions between antiepileptics and cannabinoids
- (2019) Barbara Miziak et al. Expert Opinion on Drug Metabolism & Toxicology
- Efficacy, tolerability and safety of cannabis-based medicines for cancer pain
- (2019) Winfried Häuser et al. SCHMERZ
- The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
- (2019) Albert Batalla et al. Journal of Clinical Medicine
- The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis
- (2019) Karma Rabgay et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
- (2019) Orsolini et al. Medicina-Lithuania
- Efficacy and adverse event profile of cannabidiol and medicinal cannabis for treatment-resistant epilepsy: Systematic review and meta-analysis
- (2019) Renandro de Carvalho Reis et al. EPILEPSY & BEHAVIOR
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence
- (2018) Emily Stockings et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
- (2018) Douglas L. Boggs et al. PSYCHOPHARMACOLOGY
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
- (2018) Simona Lattanzi et al. DRUGS
- Cannabis-based products for pediatric epilepsy: A systematic review
- (2018) Jesse Elliott et al. EPILEPSIA
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews
- (2017) W. Häuser et al. EUROPEAN JOURNAL OF PAIN
- Medical Cannabinoids in Children and Adolescents: A Systematic Review
- (2017) Shane Shucheng Wong et al. PEDIATRICS
- Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
- (2017) Alline C. Campos et al. Frontiers in Pharmacology
- A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders
- (2017) Keane Lim et al. Clinical Psychopharmacology and Neuroscience
- Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
- (2016) Khalid A. Jadoon et al. DIABETES CARE
- A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications
- (2016) Samuel T. Wilkinson et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
- (2016) Nora D. Volkow et al. JAMA Psychiatry
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Cannabinoids for Medical Use
- (2015) Penny F. Whiting et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems
- (2015) Kevin P. Hill JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Endocannabinoid signaling at the periphery: 50 years after THC
- (2015) Mauro Maccarrone et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies
- (2014) Mauro Maccarrone et al. NATURE REVIEWS NEUROSCIENCE
- Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology
- (2014) B. S. Koppel et al. NEUROLOGY
- Valproic acid pathway
- (2013) Yogita Ghodke-Puranik et al. Pharmacogenetics and Genomics
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search